trending Market Intelligence /marketintelligence/en/news-insights/trending/N9lms0nZ59bAqr_MEbTIfg2 content esgSubNav
In This List

Ultragenyx appoints independent director

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Ultragenyx appoints independent director

Ultragenyx Pharmaceutical Inc. appointed Deborah Dunsire to the company's board of directors.

Dunsire, currently president and CEO of XTuit Pharmaceuticals Inc., will serve as an independent director on Ultragenyx's board.